Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
13.00
-0.35 (-2.62%)
At close: Aug 15, 2025, 10:04 AM
-2.62% (1D)
| Bid | 12.98 |
| Market Cap | 570.06M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -80.91M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -7.69 |
| Forward PE | -3.83 |
| Analyst | Buy |
| Ask | 13.29 |
| Volume | 16,618 |
| Avg. Volume (20D) | 126,627 |
| Open | 13.42 |
| Previous Close | 13.35 |
| Day's Range | 12.99 - 13.50 |
| 52-Week Range | 6.71 - 19.19 |
| Beta | 3.13 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+24.26%
Maze Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
-10.08%
Maze Therapeutics shares are trading lower on possible continued weakness after the company reported a year-over-year decrease in Q4 EPS results yesterday.
6 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...